NCT00514137: Sunitinib in Treating Patients With Relapsed Multiple Myeloma |
|
|
| Completed | 2 | 13 | US | sunitinib malate, SU11248, sunitinib, Sutent | National Cancer Institute (NCI) | Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma | 03/09 | 08/10 | | |
